GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,000 | +100.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | -20.0% | 44 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | -54.5% | 44 | -63.3% | 0.00% | -50.0% |
| Q1 2020 | $11,000 | -42.1% | 120 | -35.5% | 0.00% | -33.3% |
| Q4 2019 | $19,000 | -9.5% | 186 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $21,000 | -34.4% | 186 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $32,000 | +3.2% | 186 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $31,000 | +72.2% | 186 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $18,000 | -43.8% | 186 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $32,000 | +23.1% | 186 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $26,000 | +13.0% | 186 | -10.6% | 0.01% | +20.0% |
| Q1 2018 | $23,000 | +283.3% | 208 | +372.7% | 0.01% | +150.0% |
| Q4 2017 | $6,000 | – | 44 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |